These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33187589)

  • 1. Comprehensive 2D-Quantitative Structure-Activity Relationship Study on Monobactam Analogues Against Gram-Negative Bacteria.
    Zhang D; Zhang X; Li Z; Tang S; Guo Z; Hu C; Zhang J; Song D; Li Y
    J Biomed Nanotechnol; 2020 Jun; 16(6):941-953. PubMed ID: 33187589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
    Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
    Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
    Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
    Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
    Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
    Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
    J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial evaluation of new monobactams.
    Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
    Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
    Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
    Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
    J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
    Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
    Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 13. Ebselen bearing polar functionality: Identification of potent antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Chen C; Yang K
    Bioorg Chem; 2019 Dec; 93():103286. PubMed ID: 31585265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2010 Nov; 65(11):2382-95. PubMed ID: 20846937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
    Hornsey M; Phee L; Stubbings W; Wareham DW
    Int J Antimicrob Agents; 2013 Oct; 42(4):343-6. PubMed ID: 23837926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology for Monobactam Diversification: Syntheses and Studies of 4-Thiomethyl Substituted β-Lactams with Activity against Gram-Negative Bacteria, Including Carbapenemase Producing Acinetobacter baumannii.
    Carosso S; Liu R; Miller PA; Hecker SJ; Glinka T; Miller MJ
    J Med Chem; 2017 Nov; 60(21):8933-8944. PubMed ID: 28994597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
    Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
    Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.